These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2291411)

  • 41. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The DST as a predictor of outcome in depression: a meta-analysis.
    Ribeiro SC; Tandon R; Grunhaus L; Greden JF
    Am J Psychiatry; 1993 Nov; 150(11):1618-29. PubMed ID: 8214170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexamethasone suppression test and TRH test in endogenous depression.
    Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
    Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
    Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dexamethasone suppression test in relation to symptomatology: preliminary findings controlling for serum dexamethasone concentrations.
    Smith J; Carr V; Morris H; Gilliland J
    Psychiatry Res; 1988 Aug; 25(2):123-33. PubMed ID: 3174902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal variation and the results of the dexamethasone suppression test.
    Harris B; Watkins S; Newcombe R; Cook N; Read G; Riad-Fahmy D
    J Affect Disord; 1990 Oct; 20(2):115-20. PubMed ID: 2148325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression.
    Grunhaus L; Flegel P; Carroll BJ; Greden JF
    J Affect Disord; 1985; 8(1):1-7. PubMed ID: 3156907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between the dexamethasone suppression test in depressed patients and clinical response.
    Nemeroff CB; Evans DL
    Am J Psychiatry; 1984 Feb; 141(2):247-9. PubMed ID: 6691487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline.
    Kin NM; Nair NP; Amin M; Schwartz G; Ahmed SK; Holm P; Katona C; Kragh-Sorensen P; Klitgaard N; Song WY; West TE; Stage K
    Biol Psychiatry; 1997 Nov; 42(10):925-31. PubMed ID: 9359979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dexamethasone suppression test in organic affective syndrome.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1984 Nov; 141(11):1465-7. PubMed ID: 6496794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consistent reversal of abnormal DSTs after different antidepressant therapies in a patient with dementia.
    Wamboldt MZ; Kalin NH; Weiler SJ
    Am J Psychiatry; 1985 Jan; 142(1):100-3. PubMed ID: 3966566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone suppression test in recently detoxified alcoholics: clinical implications.
    Khan A; Ciraulo DA; Nelson WH; Becker JT; Nies A; Jaffe JH
    J Clin Psychopharmacol; 1984 Apr; 4(2):94-7. PubMed ID: 6707246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The dexamethasone suppression test with mildly to moderately depressed outpatients.
    Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J
    Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.